Pancreatic Cancer - Global Market Outlook (2017-2026)

Pancreatic Cancer - Global Market Outlook (2017-2026)

According to Stratistics MRC, the Global Pancreatic Cancer market is accounted for $1,904.20 million in 2017 and is expected to reach $4,728.19 million by 2026 growing at a CAGR of 10.6% during the forecast period. Advancement of technology in therapeutic devices and expanding prevalence of cancer growth are the factors driving the market. However, accessibility of costly treatment and poor repayment strategies in the emerging regions of the world are some of the factors which may hamper the market growth during the forecast period.

Pancreatic Cancer is a type of cancer that starts in the pancreas. It is a highly lethal disease, for which mortality closely parallels incidence. Most patients with Pancreatic Cancer remain asymptomatic until the disease reaches an advanced stage. There is no standard programme for screening patients at high risk of Pancreatic Cancer. Most Pancreatic Cancers arise from microscopic non-invasive epithelial proliferations within the pancreatic ducts, referred to as pancreatic intraepithelial neoplasias.

Based on the treatment, the biologic therapy has a huge demand due to expanding number of novel upcoming immunotherapies as well as focused cell therapy that treats the cancer with no extreme symptoms and has more number of helpful advantages over the conventional chemotherapies.

By geography, Asia Pacific is growing lucratively during the forecast period owing to the nearness of quickly creating medicinal services innovation, high patient population, and high social insurance use. Additionally, expanding interest for new treatment strategies in nations like India and South Korea is probably going to develop as the quickest developing business sector over the globe.

Some of the key players in the Pancreatic Cancer market include Novartis Ag, Eli Lily and Company, F. Hoffmann-La Roche AG, Pharmacyte Biotech, Inc, Clovis Oncology, Celgene Corporation, Teva Pharmaceutical Industries Ltd., Amgen, Inc., Pfizer, Inc. and Merck & Co., Inc.

Treatments Covered:
• Biologic Therapy
• Hormone Therapy
• Chemotherapy
• Targeted Therapy
• Surgery
• Radiation Therapy
• Other Treatments

Types Covered:
• Exocrine Pancreas Cancer
• Endocrine Pancreas Cancer

End Users Covered:
• Research Institute
• Hospitals & Clinics
• Other End Users

Regions Covered:
• North America
US
Canada
Mexico
• Europe
Germany
UK
Italy
France
Spain
Rest of Europe
• Asia Pacific
Japan
China
India
Australia
New Zealand
South Korea
Rest of Asia Pacific
• South America
Argentina
Brazil
Chile
Rest of South America
• Middle East & Africa
Saudi Arabia
UAE
Qatar
South Africa
Rest of Middle East & Africa

What our report offers:
- Market share assessments for the regional and country level segments
- Strategic recommendations for the new entrants
- Market forecasts for a minimum of 9 years of all the mentioned segments, sub segments and the regional markets
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic analysis: Drivers and Constraints, Product/Technology Analysis, Porter’s five forces analysis, SWOT analysis etc.
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements

Free Customization Offerings:
All the customers of this report will be entitled to receive one of the following free customization options:
• Company Profiling
Comprehensive profiling of additional market players (up to 3)
SWOT Analysis of key players (up to 3)
• Regional Segmentation
Market estimations, Forecasts and CAGR of any prominent country as per the clients interest (Note: Depends of feasibility check)
• Competitive Benchmarking
Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances.


1 Executive Summary
2 Preface
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions
3 Market Trend Analysis
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 End User Analysis
3.7 Emerging Markets
3.8 Futuristic Market Scenario
4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry
5 Global Pancreatic Cancer Market, By Treatment
5.1 Introduction
5.2 Biologic Therapy
5.3 Hormone Therapy
5.4 Chemotherapy
5.5 Targeted Therapy
5.6 Surgery
5.7 Radiation Therapy
5.8 Other Treatments
6 Global Pancreatic Cancer Market, By Type
6.1 Introduction
6.2 Exocrine Pancreas Cancer
6.3 Endocrine Pancreas Cancer
7 Global Pancreatic Cancer Market, By End User
7.1 Introduction
7.2 Research Institute
7.3 Hospitals & Clinics
7.4 Other End Users
8 Global Pancreatic Cancer Market, By Geography
8.1 Introduction
8.2 North America
8.2.1 US
8.2.2 Canada
8.2.3 Mexico
8.3 Europe
8.3.1 Germany
8.3.2 UK
8.3.3 Italy
8.3.4 France
8.3.5 Spain
8.3.6 Rest of Europe
8.4 Asia Pacific
8.4.1 Japan
8.4.2 China
8.4.3 India
8.4.4 Australia
8.4.5 New Zealand
8.4.6 South Korea
8.4.7 Rest of Asia Pacific
8.5 South America
8.5.1 Argentina
8.5.2 Brazil
8.5.3 Chile
8.5.4 Rest of South America
8.6 Middle East & Africa
8.6.1 Saudi Arabia
8.6.2 UAE
8.6.3 Qatar
8.6.4 South Africa
8.6.5 Rest of Middle East & Africa
9 Key Developments
9.1 Agreements, Partnerships, Collaborations and Joint Ventures
9.2 Acquisitions & Mergers
9.3 New Product Launch
9.4 Expansions
9.5 Other Key Strategies
10 Company Profiling
10.1 Novartis Ag
10.2 Eli Lily and Company
10.3 F. Hoffmann-La Roche AG
10.4 Pharmacyte Biotech, Inc
10.5 Clovis Oncology
10.6 Celgene Corporation
10.7 Teva Pharmaceutical Industries Ltd.
10.8 Amgen, Inc.
10.9 Pfizer, Inc.
10.10 Merck & Co., Inc.
List of Tables
Table 1 Global Pancreatic Cancer Market Outlook, By Region (2016-2026) (US $MN)
Table 2 Global Pancreatic Cancer Market Outlook, By Treatment (2016-2026) (US $MN)
Table 3 Global Pancreatic Cancer Market Outlook, By Biologic Therapy (2016-2026) (US $MN)
Table 4 Global Pancreatic Cancer Market Outlook, By Hormone Therapy (2016-2026) (US $MN)
Table 5 Global Pancreatic Cancer Market Outlook, By Chemotherapy (2016-2026) (US $MN)
Table 6 Global Pancreatic Cancer Market Outlook, By Targeted Therapy (2016-2026) (US $MN)
Table 7 Global Pancreatic Cancer Market Outlook, By Surgery (2016-2026) (US $MN)
Table 8 Global Pancreatic Cancer Market Outlook, By Radiation Therapy (2016-2026) (US $MN)
Table 9 Global Pancreatic Cancer Market Outlook, By Other Treatments (2016-2026) (US $MN)
Table 10 Global Pancreatic Cancer Market Outlook, By Type (2016-2026) (US $MN)
Table 11 Global Pancreatic Cancer Market Outlook, By Exocrine Pancreas Cancer (2016-2026) (US $MN)
Table 12 Global Pancreatic Cancer Market Outlook, By Endocrine Pancreas Cancer (2016-2026) (US $MN)
Table 13 Global Pancreatic Cancer Market Outlook, By End User (2016-2026) (US $MN)
Table 14 Global Pancreatic Cancer Market Outlook, By Research Institute (2016-2026) (US $MN)
Table 15 Global Pancreatic Cancer Market Outlook, By Hospitals & Clinics (2016-2026) (US $MN)
Table 16 Global Pancreatic Cancer Market Outlook, By Other End Users (2016-2026) (US $MN)
Table 17 North America Pancreatic Cancer Market Outlook, By Country (2016-2026) (US $MN)
Table 18 North America Pancreatic Cancer Market Outlook, By Treatment (2016-2026) (US $MN)
Table 19 North America Pancreatic Cancer Market Outlook, By Biologic Therapy (2016-2026) (US $MN)
Table 20 North America Pancreatic Cancer Market Outlook, By Hormone Therapy (2016-2026) (US $MN)
Table 21 North America Pancreatic Cancer Market Outlook, By Chemotherapy (2016-2026) (US $MN)
Table 22 North America Pancreatic Cancer Market Outlook, By Targeted Therapy (2016-2026) (US $MN)
Table 23 North America Pancreatic Cancer Market Outlook, By Surgery (2016-2026) (US $MN)
Table 24 North America Pancreatic Cancer Market Outlook, By Radiation Therapy (2016-2026) (US $MN)
Table 25 North America Pancreatic Cancer Market Outlook, By Other Treatments (2016-2026) (US $MN)
Table 26 North America Pancreatic Cancer Market Outlook, By Type (2016-2026) (US $MN)
Table 27 North America Pancreatic Cancer Market Outlook, By Exocrine Pancreas Cancer (2016-2026) (US $MN)
Table 28 North America Pancreatic Cancer Market Outlook, By Endocrine Pancreas Cancer (2016-2026) (US $MN)
Table 29 North America Pancreatic Cancer Market Outlook, By End User (2016-2026) (US $MN)
Table 30 North America Pancreatic Cancer Market Outlook, By Research Institute (2016-2026) (US $MN)
Table 31 North America Pancreatic Cancer Market Outlook, By Hospitals & Clinics (2016-2026) (US $MN)
Table 32 North America Pancreatic Cancer Market Outlook, By Other End Users (2016-2026) (US $MN)
Table 33 Europe Pancreatic Cancer Market Outlook, By Country (2016-2026) (US $MN)
Table 34 Europe Pancreatic Cancer Market Outlook, By Treatment (2016-2026) (US $MN)
Table 35 Europe Pancreatic Cancer Market Outlook, By Biologic Therapy (2016-2026) (US $MN)
Table 36 Europe Pancreatic Cancer Market Outlook, By Hormone Therapy (2016-2026) (US $MN)
Table 37 Europe Pancreatic Cancer Market Outlook, By Chemotherapy (2016-2026) (US $MN)
Table 38 Europe Pancreatic Cancer Market Outlook, By Targeted Therapy (2016-2026) (US $MN)
Table 39 Europe Pancreatic Cancer Market Outlook, By Surgery (2016-2026) (US $MN)
Table 40 Europe Pancreatic Cancer Market Outlook, By Radiation Therapy (2016-2026) (US $MN)
Table 41 Europe Pancreatic Cancer Market Outlook, By Other Treatments (2016-2026) (US $MN)
Table 42 Europe Pancreatic Cancer Market Outlook, By Type (2016-2026) (US $MN)
Table 43 Europe Pancreatic Cancer Market Outlook, By Exocrine Pancreas Cancer (2016-2026) (US $MN)
Table 44 Europe Pancreatic Cancer Market Outlook, By Endocrine Pancreas Cancer (2016-2026) (US $MN)
Table 45 Europe Pancreatic Cancer Market Outlook, By End User (2016-2026) (US $MN)
Table 46 Europe Pancreatic Cancer Market Outlook, By Research Institute (2016-2026) (US $MN)
Table 47 Europe Pancreatic Cancer Market Outlook, By Hospitals & Clinics (2016-2026) (US $MN)
Table 48 Europe Pancreatic Cancer Market Outlook, By Other End Users (2016-2026) (US $MN)
Table 49 Asia Pacifc Pancreatic Cancer Market Outlook, By Country (2016-2026) (US $MN)
Table 50 Asia Pacifc Pancreatic Cancer Market Outlook, By Treatment (2016-2026) (US $MN)
Table 51 Asia Pacifc Pancreatic Cancer Market Outlook, By Biologic Therapy (2016-2026) (US $MN)
Table 52 Asia Pacifc Pancreatic Cancer Market Outlook, By Hormone Therapy (2016-2026) (US $MN)
Table 53 Asia Pacifc Pancreatic Cancer Market Outlook, By Chemotherapy (2016-2026) (US $MN)
Table 54 Asia Pacifc Pancreatic Cancer Market Outlook, By Targeted Therapy (2016-2026) (US $MN)
Table 55 Asia Pacifc Pancreatic Cancer Market Outlook, By Surgery (2016-2026) (US $MN)
Table 56 Asia Pacifc Pancreatic Cancer Market Outlook, By Radiation Therapy (2016-2026) (US $MN)
Table 57 Asia Pacifc Pancreatic Cancer Market Outlook, By Other Treatments (2016-2026) (US $MN)
Table 58 Asia Pacifc Pancreatic Cancer Market Outlook, By Type (2016-2026) (US $MN)
Table 59 Asia Pacifc Pancreatic Cancer Market Outlook, By Exocrine Pancreas Cancer (2016-2026) (US $MN)
Table 60 Asia Pacifc Pancreatic Cancer Market Outlook, By Endocrine Pancreas Cancer (2016-2026) (US $MN)
Table 61 Asia Pacifc Pancreatic Cancer Market Outlook, By End User (2016-2026) (US $MN)
Table 62 Asia Pacifc Pancreatic Cancer Market Outlook, By Research Institute (2016-2026) (US $MN)
Table 63 Asia Pacifc Pancreatic Cancer Market Outlook, By Hospitals & Clinics (2016-2026) (US $MN)
Table 64 Asia Pacifc Pancreatic Cancer Market Outlook, By Other End Users (2016-2026) (US $MN)
Table 65 South America Pancreatic Cancer Market Outlook, By Country (2016-2026) (US $MN)
Table 66 South America Pancreatic Cancer Market Outlook, By Treatment (2016-2026) (US $MN)
Table 67 South America Pancreatic Cancer Market Outlook, By Biologic Therapy (2016-2026) (US $MN)
Table 68 South America Pancreatic Cancer Market Outlook, By Hormone Therapy (2016-2026) (US $MN)
Table 69 South America Pancreatic Cancer Market Outlook, By Chemotherapy (2016-2026) (US $MN)
Table 70 South America Pancreatic Cancer Market Outlook, By Targeted Therapy (2016-2026) (US $MN)
Table 71 South America Pancreatic Cancer Market Outlook, By Surgery (2016-2026) (US $MN)
Table 72 South America Pancreatic Cancer Market Outlook, By Radiation Therapy (2016-2026) (US $MN)
Table 73 South America Pancreatic Cancer Market Outlook, By Other Treatments (2016-2026) (US $MN)
Table 74 South America Pancreatic Cancer Market Outlook, By Type (2016-2026) (US $MN)
Table 75 South America Pancreatic Cancer Market Outlook, By Exocrine Pancreas Cancer (2016-2026) (US $MN)
Table 76 South America Pancreatic Cancer Market Outlook, By Endocrine Pancreas Cancer (2016-2026) (US $MN)
Table 77 South America Pancreatic Cancer Market Outlook, By End User (2016-2026) (US $MN)
Table 78 South America Pancreatic Cancer Market Outlook, By Research Institute (2016-2026) (US $MN)
Table 79 South America Pancreatic Cancer Market Outlook, By Hospitals & Clinics (2016-2026) (US $MN)
Table 80 South America Pancreatic Cancer Market Outlook, By Other End Users (2016-2026) (US $MN)
Table 81 Middle East & Africa Pancreatic Cancer Market Outlook, By Country (2016-2026) (US $MN)
Table 82 Middle East & Africa Pancreatic Cancer Market Outlook, By Treatment (2016-2026) (US $MN)
Table 83 Middle East & Africa Pancreatic Cancer Market Outlook, By Biologic Therapy (2016-2026) (US $MN)
Table 84 Middle East & Africa Pancreatic Cancer Market Outlook, By Hormone Therapy (2016-2026) (US $MN)
Table 85 Middle East & Africa Pancreatic Cancer Market Outlook, By Chemotherapy (2016-2026) (US $MN)
Table 86 Middle East & Africa Pancreatic Cancer Market Outlook, By Targeted Therapy (2016-2026) (US $MN)
Table 87 Middle East & Africa Pancreatic Cancer Market Outlook, By Surgery (2016-2026) (US $MN)
Table 88 Middle East & Africa Pancreatic Cancer Market Outlook, By Radiation Therapy (2016-2026) (US $MN)
Table 89 Middle East & Africa Pancreatic Cancer Market Outlook, By Other Treatments (2016-2026) (US $MN)
Table 90 Middle East & Africa Pancreatic Cancer Market Outlook, By Type (2016-2026) (US $MN)
Table 91 Middle East & Africa Pancreatic Cancer Market Outlook, By Exocrine Pancreas Cancer (2016-2026) (US $MN)
Table 92 Middle East & Africa Pancreatic Cancer Market Outlook, By Endocrine Pancreas Cancer (2016-2026) (US $MN)
Table 93 Middle East & Africa Pancreatic Cancer Market Outlook, By End User (2016-2026) (US $MN)
Table 94 Middle East & Africa Pancreatic Cancer Market Outlook, By Research Institute (2016-2026) (US $MN)
Table 95 Middle East & Africa Pancreatic Cancer Market Outlook, By Hospitals & Clinics (2016-2026) (US $MN)
Table 96 Middle East & Africa Pancreatic Cancer Market Outlook, By Other End Users (2016-2026) (US $MN)

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook